光宇生醫

解決方案&服務內容

Start-up founded with 4 people and admitted into Biomedical Science Park accelerator in Hsinchu.
1st Proprietary Biomaterial Pilot Plant: Established a biomaterials research lab, proprietary biomedical materials pilot plant, and medical-grade printing system.
Admitted Into Hsinchu Science Park, Capital Injected With 1 Million USD.
應用領域：骨骼/肌肉/結締組織相關(Musculoskeletal Sys. & Cnnct. Tiss.),生技產業(Industrial Biotechnology),呼吸系統相關(Respiratory)
技術領域：生物材料(Biomaterials),合成材料(Synthetic Materials),主動植入式醫療器材(AIMD, Active Implantable Medical Devices),委託製造(CMO, Contract Manufacturing Organization),表面塗層(Coatings),醫療設備(Medical Devices),再生醫學(Regenerative Medicine)
事件或專利: MeDFila®PCL-陶瓷(70:30)複合列印材料，獲美國食品藥物管理局(FDA)通知獲准原料主檔案之建立，取得FDA頒發之MAF證號。
年分日期: 2018/9
產品名稱: 醫療級3D列印原料 (1.長時間可吸收複合配方, 2. 不可吸收配方 3. 含有陶瓷相容材質配方